V(D)J RECOMBINASE & CHROMOSOME TRANSLOCATION IN LYMPHOMA

V(D)J 重组酶

• 批准号: 6800678
• 负责人: K GARY VANASSE
• 金额: $ 13.04万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-07-07 至 2005-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6800678
• 关键词: B cell lymphoma; DNA damage; DNA repair; SCID mouse; carcinogenesis; chromosome translocation; enzyme activity; fluorescent in situ hybridization; gene expression; gene mutation; gene rearrangement; genetic library; immunoglobulin genes; molecular cloning; neoplasm /cancer genetics; nucleic acid sequence; protein kinase C; recombinase

Lymphomas are a significant cause of morbidity and mortality in humans. Whereas protooncogenes involved in lymphoma formation have been identified, the complete genetic pathways resulting in lymphomas remain elusive. The majority of human lymphomas have been noted to have chromosomal translocations, and most of these involve the immunoglobulin (Ig) loci. Evidence suggests that V(D)J recombination, which represents a regulated form of genetic instability, may mediate chromosomal translocations resulting in the deregulated expression of genes affecting lymphocyte growth or survival. The fact that lymphomagenic events are rare underscores the existence of cellular mechanisms to prevent aberrant V(D)J recombination. Mice with mutations in the SCID gene are severely limited in their ability to effectively repair coding ends to generate functional antigen receptors and have defective double strand DNA break repair, indicating that the SCID gene product plays a role in both V(D)J recombination and double strand DNA break repair. SCID x p53 -/- mice uniformly develop disseminated B cell lymphomas, which we have discovered contain recurrent t(12;15) involving the IgH locus. We have, thus, defined a genetic pathway leading to a particular chromosomal translocation, possibly involving the V(D)J recombinase mechanism. We propose to use FISH analysis to map and clone the chromosome 12 translocation breakpoint, examining the sequence for characteristics of V(D)J recombination and identifying potential oncogenes. Using a mouse model, we propose to investigate whether absence of V(D)J recombination suppresses the development of aggressive pro-B cell lymphomas. The long term goal of this project will be to study the role of V(D)J recombination as a potential genetic pathway for chromosomal translocations leading to the development of lymphomas. Such insight may further the understanding of lymphomagenesis and may help in the development of novel anti-tumor strategies.

淋巴瘤是人类发病率和死亡率的重要原因。 虽然参与淋巴瘤形成的原癌基因已经被确定，但导致淋巴瘤的完整遗传途径仍然难以捉摸。 大多数人类淋巴瘤已注意到有染色体易位，其中大多数涉及免疫球蛋白（IG）基因座。 有证据表明，V（D）J重组，这代表了一种调节形式的遗传不稳定性，可能介导染色体易位，导致影响淋巴细胞生长或存活的基因表达失调。 事实上，淋巴瘤的事件是罕见的强调存在细胞机制，以防止异常V（D）J重组。 SCID基因突变的小鼠在有效修复编码末端以产生功能性抗原受体的能力方面受到严重限制，并且具有缺陷的双链DNA断裂修复，这表明SCID基因产物在V（D）J重组和双链DNA断裂修复中起作用。 SCID x p53 -/-小鼠均发生播散性B细胞淋巴瘤，我们发现其含有涉及IgH位点的复发性t（12;15）。 因此，我们已经确定了导致特定染色体易位的遗传途径，可能涉及V（D）J重组酶机制。 我们建议使用FISH分析来定位和克隆12号染色体易位断裂点，检查序列的V（D）J重组的特征，并确定潜在的致癌基因。 使用小鼠模型，我们建议调查是否缺乏V（D）J重组抑制侵袭性前B细胞淋巴瘤的发展。该项目的长期目标是研究V（D）J重组作为染色体易位导致淋巴瘤发展的潜在遗传途径的作用。 这种见解可能会进一步了解淋巴瘤的发生，并可能有助于开发新的抗肿瘤策略。

项目成果

Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.

• DOI: 10.1158/1541-7786.620.2.11
• 发表时间: 2004-11
• 期刊: Molecular cancer research : MCR
• 作者: G. Vanasse;R. Winn;S. Rodov;A. Zieske;John T. Li;J. Tupper;Jingjing Tang;E. Raines;M. Peters;K. Y. Yeung;J. Harlan